Skip to main content
. 2018 Mar 30;15(6):8627–8634. doi: 10.3892/ol.2018.8399

Table I.

Tumor volume in each group.

Tumor volume, mm3

Treatment group 0 7 days 14 days 21 days 28 days
Control (n=6) 58.9±6.4 85.6±6.8 88.7±18.7 84.7±12.4 102.2±17.6
Saline (n=6) 62.2±7.9 98.7±25.9 79.0±15.5 77.9±24.8 94.6±10.5
Bevacizumab (n=6) 70.2±29.5 64.9±30.2 40.0±10.6 48.1±21.2 57.1±28.4

Tumor volume presented as mean ± SD.